EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | -16.7% | 90 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -93.5% | 90 | -91.0% | 0.00% | -100.0% |
| Q1 2021 | $92,000 | 0.0% | 998 | -3.1% | 0.01% | -14.3% |
| Q4 2020 | $92,000 | -4.2% | 1,030 | +10.0% | 0.01% | -12.5% |
| Q3 2020 | $96,000 | +4.3% | 936 | -19.9% | 0.01% | 0.0% |
| Q2 2020 | $92,000 | +21.1% | 1,168 | -10.8% | 0.01% | 0.0% |
| Q1 2020 | $76,000 | -5.0% | 1,310 | -12.2% | 0.01% | +14.3% |
| Q4 2019 | $80,000 | -20.0% | 1,492 | -22.4% | 0.01% | -30.0% |
| Q3 2019 | $100,000 | -28.1% | 1,922 | -33.4% | 0.01% | -28.6% |
| Q2 2019 | $139,000 | -2.1% | 2,884 | +2.6% | 0.01% | -6.7% |
| Q1 2019 | $142,000 | -2.1% | 2,812 | +15.0% | 0.02% | -11.8% |
| Q4 2018 | $145,000 | +237.2% | 2,446 | +272.9% | 0.02% | +240.0% |
| Q3 2018 | $43,000 | +30.3% | 656 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $33,000 | -8.3% | 656 | -4.1% | 0.00% | 0.0% |
| Q1 2018 | $36,000 | +3500.0% | 684 | +3320.0% | 0.00% | – |
| Q4 2017 | $1,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |